[Experimental studies of 9-(1, 3-dihydroxy-2-propoxymethyl)-guanine(DHPG) against herpes simplex virus]

Yao Xue Xue Bao. 1989;24(5):331-4.
[Article in Chinese]

Abstract

The antiherpes virus effects of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) were studied in cell culture and in experimental herpetic keratitis in rabbits. In plaque reduction assays in Vero cell, the 50% inhibitory concentration (IC50) of DHPG was shown to be 0.1 microgram/ml against HSV-1. Combination of DHPG and Cyclocytidine (CC), produced a synergistic activity against kos strains of HSV-1. Whereas the combination of DHPG and Acyclovir (ACV) or Tai-Ding-An (TDA) resulted in an additive interaction against HSV-1. Topical application of 0.1% or 0.05% DHPG eyedrop was initiated 48h after virus inoculation, significant efficacy was obtained in rabbits with herpetic epithelial keratitis. But 0.025 and 0.01% DHPG eyedrop showed no effect. 0.1% DHPG has been shown to be effective in the topical treatment of herpetic stromal keratitis in the rabbits.

MeSH terms

  • Acyclovir / pharmacology
  • Ancitabine / pharmacology
  • Animals
  • Antiviral Agents*
  • Drug Synergism
  • Ganciclovir / pharmacology*
  • Ganciclovir / therapeutic use
  • Keratitis, Dendritic / drug therapy
  • Phthalimides / pharmacology
  • Rabbits
  • Simplexvirus / drug effects*
  • Thiosemicarbazones / pharmacology
  • Vero Cells

Substances

  • Antiviral Agents
  • Phthalimides
  • Thiosemicarbazones
  • Ancitabine
  • Ganciclovir
  • phtiobuzone
  • Acyclovir